Lipopolysaccharide, central in vivo biogenic amine variations, and anhedonia

NeuroReport

Volumn 9, Issue 17, 1998, Pages 3797-3802

  Borowski, Tom ^a   Kokkinidis, Larry ^b   Merali, Zul ^c   Anisman, Hymie ^a  

^a CARLETON UNIVERSITY   (Canada)

^b UNIVERSITY OF CANTERBURY   (New Zealand)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Anhedonia; Brain stimulation reward; Cytokine; Dopamine; Endotoxin; Interleukin 1; Tumor necrosis factor alpha

Indexed keywords

BIOGENIC AMINE; CYTOKINE; DOPAMINE; INTERLEUKIN 2; LIPOPOLYSACCHARIDE;

ANHEDONIA; ANIMAL EXPERIMENT; ANOREXIA; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; DOPAMINERGIC TRANSMISSION; EXPLORATORY BEHAVIOR; LATERAL HYPOTHALAMUS; LOCOMOTION; MACROPHAGE ACTIVATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REINFORCEMENT; REWARD; SEDATION;

EID: 0032410717     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199812010-00006     Document Type: Article

References (25)

1. Zuckerman SH, Shelhaas J and Butler LD. Eur J Immunol 19, 301-305 (1989).
2. Dantzer R, Bluthe RM and Aubert A. Cytokine actions on behavior. In Rothwell NJ, ed. Cytokines and the Nervous System. London: Landes, 1996: 117-144.
3. Kent S, Bret-Dibat JL, Kelley KW, and Dantzer R. Neurosci Biobehav Rev 20, 171-175 (1996).
4. Yirmiya R. Brain Res 711, 163-174 (1996).
5. Anisman H, Ravindran AV, Griffiths J, and Merali Z. Mol Psychiatry in press (1998).
6. Maes M. Prog Neuro-Psychopharmacol Biol Psychiatry 19, 11-38 (1995).
7. Anisman H and Merali Z. In Dantzer R, ed. Cytokines, Stress and Depression. New York: Plenum Press, 1998: in press.
8. Dunn AJ. Prog NeuroEndocrinImmunol 3, 26-34 (1990).
9. Lacosta S, Merali Z and Anisman H. Psychopharmacology in press (1998).
10. Linthorst ACE, Flachskamm C, Muller-Preuss P et al. J Neurosci 15, 2920-2934 (1995).
11. Zacharko RM and Anisman H. Stressor-provoked alterations of intracranial self-stimulation in the mesocorticolimbic system: An animal model of depression. In Willner P and Scheel-Kruger J, eds. The Mesolimbic Dopamine System: From Motivation to Action. New York: Wiley, 1991: 411-442.
12. Anisman H, Kokkinidis L and Merali, Z. Brain Res 731, 1-11 (1996).
13. Anisman H, Kokkinidis L, Borowski T and Merali Z. Brain Res 779, 177-187 (1998).
14. Fibiger HC and Phillips AG. Mesocorticolimbic dopamine systems and reward. In Kalivas P and Nemeroff C. eds. The Mesocorticolimbic System. New York: New York Academy of Science, 1988: 206-215.
15. Wise RA. Behav Brain Sci 8, 178-186 (1985).
16. Paxinos G and Watson C. The Rat Brain in Stereotaxic Coordinates. New York, Academic Press, 1986.
17. Dunn AJ. Interactions between the nervous system and the immune system. In Bloom FE and Kupfer DJ, eds. Psychopharmacology. The Fourth Generation of Progress. New York: Raven Press. 1995: 719-731.
18. Deutch AY and Roth RH. Prog Brain Res 85, 367-403 (1990).
19. Song C, Merali Z and Anisman H. Neuroscience, in press (1998).
20. Merali Z, Lacosta S and Anisman H. Brain Res 761, 225-235 (1997).
21. Hayley S, Brebner K, Merali Z and Anisman H. Soc Neurosci Abstr 24 (1998) in press.
22. Brebner K, Hayley S, Merali Z and Anisman H. Soc Neurosci Abstr 24 (1998) in press.
23. Sonti G, Ilyin SE and Plata-Salaman CR. Am J Physiol 270, R1394-1402 (1996).
24. Zhou DH, Shanks N, Riechman SE et al. Neuroendocrinology 63, 227-236 (1996).
25. Maier SF and Watkins LR. Psychol Rev 105, 83-107 (1998).